Cannabis Strategic Ventures, Inc. (NUGS) Continues Expansion with Move into CBD Pet Food Supplement Line

• Acquired controlling interest in The Asher House Pet CBD brand, produced with full-spectrum, whole-plant hemp, free of THC and pesticides
• An estimated $72.13 billion will be spent on pets by Americans during 2018, with over $33 billion spent on veterinary care, supplies and OTC medicines
• Percentage of U.S. households with a pet increased from 56 percent in 1988 to 68 percent in 2018
• Sales of CBD products to U.S. consumers estimated to reach $2.1 billion by 2020, with $450 million coming from hemp-based sources
• The U.S. cannabis market is growing at an accelerated rate; industry analysts projecting a $50 billion marketplace by 2026

When it comes to taking care of household pets, Americans are spending billions to get the job done right, according to the American Pet Products Association. In 2018 alone, U.S. consumers will spend an estimated $72 billion on pets, and that includes $33 billion on veterinary care, supplies and over-the-counter medicine (http://ibn.fm/p3kRj). Cannabis Strategic Ventures, Inc. (OTC: NUGS) is expanding its diverse portfolio by moving into the pet care arena through its acquisition of The Asher House Pet CBD brand from The Asher House LLC, as detailed in a recent news release (http://ibn.fm/56Lm1).

Under the terms of the brand acquisition agreement, Cannabis Strategic Ventures will acquire controlling interest in the Asher House Pet CBD line, a brand of U.S. hemp-derived cannabidiol (CBD) supplements for pets that continues to gain national attention and is expanding internationally. Lee Asher and Luke Barton, founders of The Asher House, are currently on a whirlwind cross-country tour, working with animal shelters, pet rescues and humane societies to help erase the homeless pet population and increase awareness of pet health.

“Through the Asher House acquisition, Cannabis Strategic continues to expand its already diverse portfolio of Cannabis focus brands and service offerings,” Simon Yu, CEO of Cannabis Strategic, stated in a news release.  “At Cannabis Strategic, we believe that investing in people is as important as investing in industry-leading products and technologies. Lee and Luke’s passion for pet adoption and pet wellness is one of the key ingredients to Asher House’s national recognition. We welcome Lee Asher and Luke Barton, the founders of Asher House, to the NUGS family.”

Research into the potential benefits of cannabidiol (CBD) on dogs is underway at Colorado State University College of Veterinary Medicine & Biomedical Sciences, supported by a $356,000 grant from The American Kennel Club Canine Health Foundation (http://ibn.fm/cPki1). Dr. Stephanie McGrath, a veterinary neurologist, received the grant to document the therapeutic potential of cannabis in dogs.

CBD is big business for human consumers as well, with sales expected to reach $2.1 billion by 2020 and $450 million of those sales coming from hemp-based sources, a Forbes article states (http://ibn.fm/cXdrg). CBD products are typically used for health reasons instead of recreational purposes, since they are derived from industrial hemp or cannabis plants with extremely low levels of THC, the psychoactive compound found in marijuana.

Cannabis Strategic’s portfolio includes the recently acquired Fitamins CBD brand, which offers vitamin- and hemp-derived CBD formulations through a network of more than 600 wholesalers serving the Asian-American market (http://ibn.fm/zPFkV). The company is also focused on supporting entrepreneurial growth in the legal cannabis sector through its personnel solutions, which are tailor-made to match the growth dynamics of this booming industry.

Cannabis Strategic pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations and branded products within the cannabis space. Carving out and controlling specific industry niches, in addition to creating and marketing unique cannabis consumer branded products for humans and pets alike, is a win-win for Cannabis Strategic and its stakeholders.

For more information, visit the company’s website at www.CannabisStrategic.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Youngevity International, Inc. (NASDAQ: YGYI) Enters the Cannabis Market with New Product Line

• Enters the $7.7B cannabis market with new product line HempFX™
• Introduced three new proprietary blends of hemp-derived cannabinoid products
• Official launch will take place in October 2018

Over 20 years ago, Youngevity International, Inc. (NASDAQ: YGYI) was founded around one central question: How can we live younger, longer? Since then, YGYI has prided itself on developing the highest quality and most well-researched nutritional products. Now a leading omni-direct lifestyle company, YGYI is putting people on a holistic path to better health.

Already offering products in the eight top selling retail categories (health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo and a range of innovative services), YGYI recently announced its entry into the $7.7 billion cannabis market with new product line HempFX™ (http://ibn.fm/MFWfQ).

Direct Selling News recently reported, “According to recent data published by Forbes, citing Brightfield Group, the global cannabis market is projected to reach $31.4 billion by 2021. By end of 2017, the global market value was estimated at $7.7 billion.” In a rapidly growing cannabis market in which industry analysts continue to forecast sustained growth, the Hemp FX™ products hold promise.

Hemp FX™ has three new proprietary blends of organically grown hemp-derived cannabinoid products. Each product utilizes YGYI’s exclusive hemp-derived cannabinoid oil and combines it with natural herbs and minerals to achieve the desired results.

Soothe™ combines YGYI’s cannabidiol oil with herbs, minerals and a powerful antioxidant to support a healthy immune system and soothe sore, tired and achy muscles and joints.

Relax™ combines the cannabidiol oil with chamomile, lavender, valerian and melatonin for sleep-supporting benefits.

Uplift™ combines the cannabidiol oil with St. John’s Wort and a specialized set of natural terpenes (cannabinoid enhancers).

Soothe™, Relax™ and Uplift™ were introduced at the 2018 Youngevity Convention in San Diego, California. A limited quantity that was available for pre-sale purchases to attendees quickly sold out. This new product line has the potential to transform both the nutritional industry and Youngevity’s consumer base.

In a news release, Steve Wallach, Youngevity’s CEO, stated, “Hemp-derived cannabidiol aligns with what we do very well. We’ve taken what we know about essential nutrients along with decades of knowledge specializing in natural, plant-based nutrition and their most beneficial nutrients and put that knowledge to work to develop high-end cannabidiol products.”

The official launch of Hemp FX™ is set to take place in October 2018.

For more information, visit the company’s website at www.YGYI.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Displays Scale as it Reports Q2 2018 Results

• Scaling up to become the largest organic cannabis brand in the world
• Grow facilities in Canada, Denmark and Jamaica to produce 195,000 kg of cannabis annually
• Announced $25.8 million acquisition of HemPoland adds gateway to huge European market
• Ecommerce giant Shopify to build online sales platform

With the release of its Q2 2018 results, a sterling performance by The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is on display (http://ibn.fm/RU5Nj). The string of achievements announced in the report shows that the company, a producer of organic, pesticide-free medical cannabis, is well on its way to realizing management’s vision of becoming the largest organic cannabis brand in the world. By the end of 2019, TGOD expects to have all of its production facilities up and running. Together, they will have the capacity to churn out 195,000 kilograms of cannabis annually.

Presently, the company is on track to achieve its ambitious goals, with four cultivation units under its aegis. The largest is the facility under construction at Valleyfield, Quebec. Work at the 72.4-acre property began soon after initial construction permits were granted in December 2017. The planned 820,000 square feet high-technology hybrid facility will have an output capacity of 142,000 kg of high-quality organic cannabis. Since it is eligible for Hydro Quebec’s economic development rate, which will lower its power cost, this facility will put TGOD in a good position to be a low cost producer. The plant is expected to be ready in the first half of 2019.

TGOD’s European operations won’t be quite as big as the Valleyfield complex, but, with a planned annual output capacity of 25,000 kg, the endeavor, focused on oil extraction, won’t be anything to sneeze at. Consisting of two facilities situated in 1.3 million sq. ft. of state-of-the-art automated greenhouses, the enterprise, currently the subject of a Letter of Intent (LOI), will be a 50/50 joint venture with Knud Jepsen, based in Hinnerup, Denmark. The expected completion date is in the second half of 2019.

However, in a recently announced acquisition that dramatically accelerates its strategic entry into Europe’s lucrative organic cannabis market, TGOD entered into a definitive agreement to acquire HemPoland, a European manufacturer and marketer of premium organic CBD oils (http://ibn.fm/qoOPs). The $25.8 million deal, which includes an immediate accretive cash and share transaction in addition to an infusion of funding for research and development, gives the cannabis-focused research and development company an enviable foothold in Europe’s multibillion dollar cannabis market, as noted by Brian Athaide, CEO of TGOD. In a news release, he stated “Gaining market share with CBD products now, in the EU, with over 700 locations, allows TGOD to establish immediate brand awareness across all verticals including infused beverages. This is an accretive acquisition and gateway to Europe’s 750 million people accelerating our plan of becoming the world’s largest organic cannabis brand.”

TGOD has already established a footprint in Jamaica. The company signed a binding agreement to acquire 49.18 percent of Epican Medicinals, a vertically integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail licenses. Epican is something of a pioneer. It was the first to be granted a cultivation license in Jamaica. Its grow facility currently has a capacity of 1,300 kg, which will be expanded to 14,000 kg by the end of 2018. Epican plans to launch a total of five dispensaries in Jamaica. The first had a successful opening in Kingston, Jamaica, on Saturday, July 14 (http://ibn.fm/ALwwO). This partnership with Epican provides TGOD with a low-cost platform to export premium Jamaican-grown cannabis to select international jurisdictions.

At its Hamilton facility, the target output capacity is also 14,000 kg. Construction is proceeding in phases. Phase 1, meant to be used as a test before scaling up, is an indoor facility covering 7,000 sq. ft., and producing 1,000 kg of cannabis. Phase 2 will add 20,000 sq. ft. in an indoor facility with a production capacity of 2,000 kg; it will focus on specialty grows and formulations. Phase 3 is a planned hybrid facility that will cover 123,000 sq. ft. and have an annual output capacity of 11,000 kg. At completion, scheduled for the first half of 2019, the Hamilton complex will extend over 150,000 sq. ft. and produce 14,000 kg of high quality organic cannabis annually.

All four facilities – Denmark, Hamilton, Jamaica and Valleyfield – are fully funded, and, on their completion, total TGOD facilities will cover 1,607,245 sq. ft. and produce 195,000 kg per annum.

To complement its brick-and-mortar operations, TGOD has engaged Shopify Inc. (NYSE: SHOP) (TSX: SHOP) to build an innovative ecommerce platform to promote and deliver medical and adult-use organic cannabis worldwide (http://ibn.fm/Dear3). Presently, Shopify is the leading cloud-based multichannel ecommerce platform. The company was involved in the partnership between TGOD and Epican in Jamaica, where it supplied the retail point-of-sale system for Epican’s retail outlets. Shopify is also developing the pre-registration system for medical patients throughout Jamaica.

For more information, visit the company’s website at www.TGOD.ca

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Unveils Brand Forward Strategy for the Cannabis Industry

Cannabis Strategic Ventures (OTC: NUGS) this morning announced its increased commitment to cannabis industry brands and innovators through the development of a proprietary branding and partnership model for the cannabis industry. As its primary investment focus, Cannabis Strategic Ventures intends to continue to develop multiple proprietary brands over the coming months. The company also aims to continue its work to enhance its infrastructure, product sourcing, communication and content support offerings. “Branding is becoming more important to the development of this industry,” Cannabis Strategic Ventures CEO Simon Yu stated in the news release. “As a firm, we predict consumer-focused cannabis brands will eventually become one of the largest categories in the cannabis industry. This is a place we want to be in and are taking steps to ensure our participation. Additionally, as the cannabis industry continues to evolve, the Cannabis Strategic Ventures business model will adapt to the changing needs of the market while remaining true to our core mission.”

To view the full press release, visit http://ibn.fm/Za2Oa

About Cannabis Strategic Ventures, Inc.

Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Earth Science Tech, Inc. (ETST) Expanding Reach and Products Globally

• Strategically positioned to be a global leader in the CBD space
• Expands CBD chocolate product line and provides accessibility to consumers in convenience stores across the U.S.
• Joint ventures globally in nutraceuticals, pharmaceuticals and medical device products

Earth Science Tech, Inc. (OTC: ETST) is a Florida-based biotechnology company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals and medical devices. The company operates through three wholly owned subsidiaries – Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc. and KannaBidioiD, Inc. – each of which are equally invested in developing the company’s role as a global leader in the CBD space. Last year, the company acquired Canna Inno Laboratories, Inc. as part of its strategic plan to expand into Canada and gain access to government grants.

By making its products more available to consumers through its association with AATAC, an advisory board that focuses on convenience stores, ETST is setting itself apart as a major provider of premium CBD products. Through a joint venture with Karmavore Superfoods, the company is expanding its unique full spectrum cannabinoid CBD raw dark chocolate line from two to five products. With the anticipated launch of three new CBD-based patent formulas – chocolate-covered mangoes, chocolate coconut peppermint cups and chocolate caramelized quinoa crunch – ETST and AATAC anticipate a high volume of preorders from approximately 90,000 retail outlets throughout the United States. These chocolates are scheduled to hit the market in the coming weeks. The move to provide this product in convenience stores provides ETST with the means to increase its consumer base across every sector of the population. In a news release  (http://ibn.fm/3NhlP), Jill Buzan, chief sales officer of ETST, stated, “This could lead to huge exponential growth for ETST’s sales in the next few months.”

The expanded reach throughout the United States is not the company’s only focus. Its goal is to become a global leader in the CBD space, and ETST is taking promising steps in that direction.

In March, ETST announced that it had received a grant from the Government of Quebec to pursue the development of three CBD-based nutraceutical provisional patent products. These products include a neuron protector, a breast protector and a product designed to improve antioxidant ingestion.

Through a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc., ETST has three products in various stages. Propovit’s purpose is to alleviate throat irritation, colds and bad breath, and it is enriched with ETST hemp oil. Bionatus is being reformulated with the addition of CBD to potentially enhance its anti-inflammatory and bronchial-dilation properties. A third product is in the planning stages, and details will be shared soon.

A pre-launch clinical study of ‘Hygee’ with Clinique Santé Amitié in Quebec, Canada, is currently being conducted. ‘Hygee’ is the name of ETST’s MSN-2 home testing medical kit designed for the detection of sexually transmitted infections (STI), such as chlamydia. This kit will be marketed worldwide, and the company anticipates approval of the trademark within the next nine to 10 months.

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

ChineseInvestors.com, Inc. (CIIX) CEO Sees CBD Subsidiary ChineseHempOil.com Achieving Long Term Market Cap in Excess of $10 Million

• In MoneyTV interview, Warren Wang, CEO of CIIX, stated that CBD division has started selling in China and California, planning expansion to more U.S. states and globally to Canada and Japan
• CIIX begins two tier referral sales program of CBD in China, offering consumers a cash commission based on referred sales and an added incentive with company stock
• Citing CV Sciences, Inc. valuation, Wang projects that CIIX’s CBD subsidiary’s market cap could reach $10-20 million; he hopes it will qualify for a future OTC or Nasdaq listing

ChineseInvestors.com, Inc. (OTCQB: CIIX) subsidiary ChineseHempOil.com, Inc. is planning to expand its operations to more states in the U.S., as well as Vancouver and Toronto in Canada and Asian markets such as Japan, CEO Warren Wang said in an interview on MoneyTV with Donald Baillargeon (http://ibn.fm/iyH29). It is already selling in China and Los Angeles, California.

Wang hopes that CIIX will spin off its CBD subsidiary, ChineseHempOil.com, Inc., by year-end. “I cannot promise anything,” he noted in the interview. “But we are looking for a listing on the OTC or a national listing on the Nasdaq Exchange within 12 months.” CIIX’s CBD division includes CBD Biotechnology Co. Ltd.; Hemp Logic, Inc.; and ChineseHempOil.com, Inc., which, combined, have already built relationships with 70 retailers in the Los Angeles market.

For now, Wang said that CIIX is one of only three companies selling CBD products in China. Wang added that CIIX recently ran its first sales seminar on CBD in China from a hotel in Shanghai. The goal is to increase and broaden the company’s consumer base, he said.

“In CBD, we are now only in Los Angeles,” Wang said of the U.S. market. “After a month or two, we have plans to expand into Northern California, then to New York, Texas and Colorado. We plan to reach Chinese-Canadians in Vancouver and Toronto. We will also look in Asia, to countries such as Japan.”

In China, it is seeking to expand its CBD cosmetic product consumer base by utilizing a two-tiered sales system. It will offer to customers who generate referral sales a commission based on those sales, as well as company stock. The goal is to build ownership of CIIX among Chinese consumers, Wang said.

Wang hopes that its CBD division will perform as well as CV Sciences, Inc. (OTCQB: CVSI). In the interview, he projected a long term $10-$20 million future market cap for ChineseHempOil.com, Inc., driven in part by sales in China. After the spinoff of CBD assets, CIIX will return to its roots in consulting, brand building and educating for the Chinese-speaking community in the U.S. and international markets.

For more information, visit the company’s website at www.ChineseInvestors.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) Extend First Milestone Option

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that it has reached an arrangement regarding its investor rights agreement with Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) to extend Aurora’s exercise deadline of its first milestone option by six weeks. The milestone option, which entitles Aurora to acquire an additional 8% of the common shares of the company, will now expire on October 12, 2018. “The Aurora partnership has been incredibly beneficial for both parties to date,” The Green Organic Dutchman Holdings CEO Brian Athaide stated in the news release. “In addition to the organic supply agreement, the value of Aurora’s initial investment has increased nearly five-fold. In turn, the assistance provided by the Aurora team has helped accelerate our progress across all divisions, and we look forward to continuing our strategic partnership as we work towards building the largest organic cannabis brand in the world.”

To view the full press release, visit http://ibn.fm/1wMRl

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities in Ontario, Quebec and Jamaica. The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX: ACB) whereby Aurora has invested approximately C$78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately C$350 million and has over 20,000 shareholders. TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively. For more information, visit the company’s website at www.TGOD.ca

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html